Cassava Sciences, Inc. (SAVA) Reports Q1 Loss of $0.48

Cassava Sciences, Inc. (NASDAQ: SAVA) reported Q1 EPS of ($0.48).

For earnings history and earnings-related data on Cassava Sciences, Inc. (SAVA) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• Trump plans to request Supreme Court rehearing on birthright citizenship
• CIGNA (CI) PT Raised to $381 at Bernstein SocGen Group